SHH and neoplasm: In 2014, the deletion of SHH in mouse models and the pharmacological reduction of SHH pathways using vismodegib was pointed out by scientists not only did not have the desired tumor suppressive effect but, in some contexts, accelerated the tumor process because it reduced the stromal desmoplasia [12, 197].